Dyslipidaemias: Clinical Trials

2 trials for Dyslipidaemias, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1 completed, 1 not yet recruiting. 2 Not applicable.

By phase and status

PhaseTrialsStatus
Not applicable2Completed 1, Not yet recruiting 1

Follow Dyslipidaemias: new trials by email Literature Review of Dyslipidaemias trials Research Report on Dyslipidaemias

Trials (filtered) newest first · largest first

All 2 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
The Efficacy of a Food Supplement Consisting of the Combination of an Olive Extract and a Myrtle Extract for the Improvement of Lipid Metabolism in Subjects With Slightly Altered Cholesterolemia Values
Food supplement (T1675), Placebo - Dyslipidaemias
Not applicableCompletedLabomar SPA1122026-03-092026-06-25
Improved Medication and Care to Achieve Lipid Targets After Carotid Surgery
Prompt Medication Adjustment and Intensive Follow-up, Standard Care - Dyslipidaemias, Carotid Artery Stenoses
Not applicableNot yet recruitingBarmherzige Brüder Linz502025-08-042025-08-07

Narrower conditions

Carotid Stenosis (1)  ·  Dyslipidemias (1)

Broader conditions

Arterial Occlusive Diseases (1)  ·  Brain Diseases (1)  ·  Cardiovascular Diseases (1)  ·  Carotid Artery Diseases (1)  ·  Central Nervous System Diseases (1)  ·  Cerebrovascular Disorders (1)  ·  Lipid Metabolism Disorders (1)  ·  Metabolic Diseases (1)  ·  Nervous System Diseases (1)  ·  Nutritional and Metabolic Diseases (1)  ·  Vascular Diseases (1)

Interventions

Dietary Supplements (1)  ·  Standard of Care (1)

Sponsors

Barmherzige Brüder Linz (1)  ·  Labomar SPA (1)

Countries

Austria (1)  ·  Italy (1)

Top investigators

Claudio C Polistina, graduated (1)  ·  Juergen Falkensammer, Associate Professor, MD (1)  ·  Martin Clodi, Professor, MD (1)